IBM's Dividend Streak Reaches 31 Years as Confluent Integration Casts Shadow Over Organic Growth

IBM raises dividend for 31st straight year, driven by strong Q1 free cash flow and software growth, but analysts flag acquisition-related dilution and stock struggles.

IBM has delivered another dividend increase for the 31st consecutive year, a feat almost unheard of in the technology sector. The board approved a quarterly payout of $1.69 per common share, payable June 10 to shareholders of record as of May 8. With a payout ratio hovering around 57% of earnings — a level the company has maintained for decades — the move underscores a commitment to shareholder returns that dates back to 1916 for quarterly distributions.

The dividend hike was backed by a strong first quarter. Free cash flow jumped 13% to $2.2 billion, the highest Q1 figure in a decade, powered by adjusted EBITDA that swelled by roughly $600 million year-over-year. Revenue reached $15.92 billion, up 6% in constant currency. The software segment was the standout: Red Hat and data-related services posted double-digit growth, while infrastructure surged 12%, driven by a 48% spike in IBM Z systems. Consulting, however, was a laggard, managing just 1% revenue growth despite a 6% rise in bookings.

Yet beneath the headline numbers, analysts are flagging a problem. BMO Capital Markets trimmed its price target, pointing out that the early close of the Confluent acquisition inflated software results. The segment grew 11.3% to $7.1 billion, but the organic picture was weaker. Management itself expects around $600 million in dilution from the integration in 2026. On the positive side, software annual recurring revenue hit $24.6 billion, up 10%, and Red Hat OpenShift reached an ARR run rate of $2.0 billion. Since early 2024, IBM has signed virtualization contracts worth more than $600 million.

Margins told a cleaner story. The operating non-GAAP margin rose to 15.7%, a gain of 195 basis points that beat analyst estimates by roughly 85 basis points. Productivity initiatives and a favorable infrastructure mix drove the improvement. Management is sticking to its full-year guidance: constant-currency revenue growth above 5%, free cash flow roughly $1 billion higher than last year, and software segment growth of at least 10%.

The infrastructure division shone in Q1, expanding 15.3% to $3.3 billion on the back of the new z17 mainframe cycle. But the company expects a low-single-digit decline in this segment for the rest of the year — a typical pattern after a strong cycle launch. IBM is positioning the z17 as a platform for enterprise AI inferencing, arguing that real-time data streams in hybrid environments can be processed more securely and compliantly on the mainframe than in the cloud.

Despite the operational momentum, the stock has struggled. Shares trade around $199, roughly 27% below the 52-week high of $271.80 and down nearly 20% year-to-date. The price dipped 1.7% on Tuesday following the BMO target adjustment. Institutional sentiment is split: Vest Financial LLC trimmed its position by 8.3%, while three insider purchases totaling 1,484 shares occurred over the past three months.

Management has acknowledged headwinds, including macroeconomic uncertainty and rising energy costs in European markets. The Confluent acquisition is also pressuring near-term operating margins. To offset these, IBM is rolling out AI-driven internal efficiency programs targeting another $1 billion in savings in 2026. The combination of dividend consistency, solid cash flows, and margin expansion gives the bulls something to hold onto — but the market is still weighing that against weak organic momentum and integration risk.